Ikarian Capital, LLC X4 Pharmaceuticals, Inc Transaction History

Ikarian Capital, LLC

$754 Million
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.69 - $1.99 $151,440 - $436,763	-219,479 Reduced 38.6%	349,133 $345,000
Q3 2022 Nov 14, 2022	SELL	$0.92 - $1.46 $1.02 Million - $1.62 Million	-1,111,136 Reduced 66.15%	568,612 $973,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $270,798 - $587,756	307,726 Added 22.43%	1,679,748 $1.62 Million
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $1.32 Million - $2.3 Million	-892,469 Reduced 39.41%	1,372,022 $2.4 Million
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $523,309 - $1.54 Million	-275,426 Reduced 10.84%	2,264,491 $5.19 Million

Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $812,559 - $1.16 Million	-179,373 Reduced 6.6%	2,539,917 $13.4 Million
Q2 2021 Aug 18, 2021	BUY	$6.49 - $9.56 $8.95 Million - $13.2 Million	1,379,310 Added 102.94%	2,719,290 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$6.49 - $9.56 $8.27 Million - $12.2 Million	-1,275,008 Reduced 48.76%	1,339,980 $8.71 Million
Q1 2021 Aug 18, 2021	BUY	$6.63 - $10.28 $9.14 Million - $14.2 Million	1,379,310 Added 111.62%	2,614,988 $22.5 Million
Q1 2021 May 17, 2021	BUY	$6.63 - $10.28 $2.71 Million - $4.21 Million	409,254 Added 49.52%	1,235,678 $10.6 Million
Q4 2020 Feb 12, 2021	BUY	$5.41 - $7.4 $550,435 - $752,905	101,744 Added 14.04%	826,424 $5.31 Million
Q3 2020 Nov 16, 2020	BUY	$6.09 - $9.15 $4.38 Million - $6.59 Million	719,680 Added 14393.6%	724,680 $4.91 Million
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $39,900 - $52,200	5,000 New	5,000 $47,000
Q1 2020 May 15, 2020	SELL	$6.03 - $11.01 $60,300 - $110,100	-10,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$9.93 - $14.33 $99,300 - $143,300	10,000 New	10,000 $107,000

Others Institutions Holding XFOR

# of Institutions

106

Shares Held

103M

Call Options Held

206K

Put Options Held

291K

Bain Capital Life Sciences Investors, LLC Boston, MA

16.9M
Shares

$9.81 Million
3.55% of portfolio
Nea Management Company, LLC Timonium, MD

15M
Shares

$8.69 Million
1.46% of portfolio
Black Rock Inc. New York, NY

8.74M
Shares

$5.07 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.83M
Shares

$4.54 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

7.13M
Shares

$4.14 Million
0.22% of portfolio

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $39.8M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account